Second allogeneic hematopoietic cell transplantation for relapse after first allografts-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Second allogeneic hematopoietic cell transplantation for relapse after first allografts

Published:2019-01-22 Issue:7 Volume:60 Page:1758-1766
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Gyurkocza Boglarka¹²³,Storb Rainer³⁴,Chauncey Thomas R.³⁴⁵,Maloney David G.³⁴,Storer Barry E.³,Sandmaier Brenda M.³⁴

Affiliation:

1. Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA;

2. Department of Medicine, Weill Cornell Medical College of Cornell University, New York, NY, USA;

3. Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;

4. Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA;

5. Marrow Transplant Unit, VA Puget Sound Health Care System, Seattle, WA, USA

Funder

National Cancer Institute

National Heart, Lung, and Blood Institute

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2018.1542149

Reference24 articles.

1. Relapse after Allogeneic Hematopoietic Cell Therapy

2. Outcomes among Patients with Recurrent High-Risk Hematologic Malignancies after Allogeneic Hematopoietic Cell Transplantation

3. Second allogeneic transplantation for relapse of malignant disease: retrospective analysis of outcome and predictive factors by the EBMT

4. Long-term outcome and prognostic factors of second allogeneic hematopoietic stem cell transplant for acute leukemia in patients with a median follow-up of ⩾10 years

5. Second allo-SCT in patients with lymphoma relapse after a first allogeneic transplantation. A retrospective study of the EBMT Lymphoma Working Party

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second Allogeneic Hematopoietic Cell Transplantation for Relapsed Adult Acute Myeloid Leukemia: Outcomes and Prognostic Factors;Transplantation and Cellular Therapy;2024-09

2. Advances in second hematopoietic stem cell transplantation;Frontiers in Immunology;2024-07-09

3. Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients;Frontiers in Oncology;2023-08-15

4. Deuxième allogreffe (mise à jour). Recommandations de la Société francophone de greffe de moelle osseuse et de thérapie cellulaire (SFGM-TC);Bulletin du Cancer;2023-04

5. Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid Leukemia;Cancers;2023-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3